Back to News
Market Impact: 0.2
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
Source: Business Wire
Legal & LitigationHealthcare & Biotech
Hagens Berman is investigating claims in a class action complaint filed on behalf of investors against PROCEPT BioRobotics (NASDAQ: PRCT). The notice provides no details on the alleged misconduct, damages, or potential financial exposure, but the litigation inquiry represents a reputational and legal overhang for the company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
PRCT-0.80
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution
- Deutsche Bank downgrades Novartis stock rating to sell on valuation
- United Therapeutics’ Rothblatt sells $4.7 million in stock
- Apple, Marriott International and 3 Stocks to Watch Heading Into Monday